Enquiry Now :
+91 8729000609, +91 7888398911 |
info@plenumbiotech.com
Teneligliptin 20mg and Metformin Hydrochloride (ER) 500 mg Tablet | Pcotin SR
Teneligliptin 20mg and Metformin Hydrochloride 500 mg Tablet | Pcotin SR
Teneligliptin 20mg and Metformin Hydrochloride 500 mg Tablet is a combination of two effective antidiabetic medicines used for the treatment of Type 2 Diabetes Mellitus. This dual-action formulation helps in controlling blood sugar levels by improving insulin function and reducing excess glucose production in the body.
Metformin is a well-known antidiabetic medication that works by lowering glucose production in the liver, delaying glucose absorption from the intestines, and improving the body’s sensitivity to insulin.
Teneligliptin, on the other hand, belongs to the DPP-4 inhibitor class. It works by increasing insulin release from the pancreas and decreasing the hormones that raise blood sugar levels. This helps in controlling both fasting and post-meal blood sugar levels effectively.
The combination of Teneligliptin 20 mg and Metformin 500 mg provides better glycemic control compared to single-drug therapy and is widely prescribed for long-term diabetes management.
Uses of Teneligliptin 20mg and Metformin Hydrochloride 500 mg Tablet
Metformin Teneligliptin Tablets are primarily used to manage diabetes and improve overall blood sugar control.
Metformin Hydrochloride
- Helps reduce glucose production in the liver
- Decreases intestinal absorption of glucose
- Improves insulin sensitivity
- Helps maintain stable blood sugar levels
Teneligliptin
- Belongs to DPP-4 inhibitor class
- Increases levels of GLP-1 hormone
- Stimulates insulin release from the pancreas
- Reduces glucose production in the liver
- Helps control post-meal blood sugar spikes
Combination Benefits
The combination of Teneligliptin and Metformin is commonly used in patients with Type 2 Diabetes Mellitus who require better blood sugar management when a single medicine is not enough. It supports improved glycemic control and enhances treatment outcomes.





